Shannon Mumenthaler is an Assistant Professor of Medicine at the Keck School of Medicine of USC and the Chief Translational Research Officer for the Lawrence J. Ellison Institute for Transformative Medicine. As Chief Translational Research Officer, she helps guide the scientific planning of the Institute, ensure the faculty have the tools they need for their research, and strategize the partnerships and goals of the institute.
Dr. Mumenthaler completed her BS in Genetics at UC Davis and then went on to earn a PhD in Cellular and Molecular Pathology at UCLA. Although her primary scientific training is in cell biology, she applies a unique multidisciplinary approach toward her research program, partnering with mathematicians, clinicians and engineers to explore critical areas in cancer. Her overall research interest focuses on the importance of the tumor microenvironment in influencing tumor progression and treatment response. She is developing more physiologically-relevant model systems that capture the microenvironmental context of a tumor and coupling these preclinical models with microscopy-based imaging pipelines to provide deeper insights into the evolving tumor.
Dr. Mumenthaler is inspired by working with colleagues from diverse scientific backgrounds to think outside the box, devise new ways of approaching cancer, create new model systems, and push the limits of cancer research.
Dr. Mumenthaler completed her BS in Genetics at UC Davis and then went on to earn a PhD in Cellular and Molecular Pathology at UCLA. Although her primary scientific training is in cell biology, she applies a unique multidisciplinary approach toward her research program, partnering with mathematicians, clinicians and engineers to explore critical areas in cancer. Her overall research interest focuses on the importance of the tumor microenvironment in influencing tumor progression and treatment response. She is developing more physiologically-relevant model systems that capture the microenvironmental context of a tumor and coupling these preclinical models with microscopy-based imaging pipelines to provide deeper insights into the evolving tumor.
Dr. Mumenthaler is inspired by working with colleagues from diverse scientific backgrounds to think outside the box, devise new ways of approaching cancer, create new model systems, and push the limits of cancer research.
